Abstract
The biological and clinical importance of cytogenetic analysis in myelodysplastic syndrome (MDS) and in acute myeloid leukemia (AML) is being increasingly recognized. Recently, cytogenetic similarities were noted between elderly de novo AML and secondary AML, suggesting common etiopathogenetic mechanisms. In the present study we analyzed the cytogenetic similarities between patients with AML of different age and patients with MDS consecutively diagnosed during a 5-year period at a single, primary referral, hematologic center. Of 246 patients aged <86 years, 195 (80%) had a cytogenetic study at diagnosis. informative metaphases were obtained in 182 cases (93%), including 17 (9.3%) with secondary mds/aml. patients were classified according to fab criteria and were subdivided into four groups: (1) ‘early mds’: 42 patients with mds of fab subtypes other than refractory anemia with excess of blasts (raeb) or raeb in transformation (raeb-t); (2) ‘late mds’: 35 patients with raeb and raeb-t; (3) ‘old aml’: 48 patients with aml aged 65 to 85 years; (4) ‘young aml’: 57 patients with aml aged <65 years. results showed that ‘late mds’ and ‘old aml’ had striking cytogenetic similarities both in the frequency of normal karyotypes (31% and 27%), single abnormalities (14% and 13%), double abnormalities (17% and 14%), complex karyotypes (37% and 46%), and numerical abnormalities (89% and 93%), as well as in the frequency of rearrangements involving chromosome 5 (20% and 31%) and 7 (27% and 27%). the only difference between the two groups was found in the median number of chromosomes involved in complex karyotypes (5 vs 8; P = 0.03). ‘Early MDS’ had significantly less complex karyotypes (21%; P < 0.05), but its cytogenetic features resembled otherwise those of ‘late mds’ and ‘old aml’, and any significant difference disappeared when patients with chronic myelomonocytic leukemia (cmml) were excluded. cmml markedly differed from other mds subtypes in the frequency of normal (57%) and of complex karyotypes (6%). secondary mds/aml and aml with trilineage dysplasia shared the same cytogenetic features of ‘late mds’ and ‘old aml’. ‘young aml’ strikingly differed from all other groups, particularly in the higher frequency of balanced translocations (29%; P < 0.001) and single karyotype abnormalities (32%; P < 0.02), and in the lower frequency of complex karyotypes (19%; P < 0.01) and of chromosome 5 (2%; P < 0.001) and 7 (9%; P < 0.01) involvement. we conclude that in a population-based series of patients, the cytogenetic profile of mds, particularly of raeb/raeb-t, was nearly identical to that of elderly patients with aml both in the frequency and in the type of chromosomal abnormalities. these results support the possibility that mds and aml of elderly patients may represent the same disease seen at different stages of evolution.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Schiffer CA, Lee EJ, Tomiyasu T, Wiernik PH, Testa JR . Prognostic impact of cytogenetic abnormalities in patients with de novo acute nonlymphocytic leukemia Blood 1989 73: 263–270
Berger R, Bernheim A, Ochoa-Noguera ME, Daniel M-T, Valensi F, Sigaux F, Flandrin G, Boiron M . Prognostic significance of chromosomal abnormalities in acute nonlymphocytic leukemia: a study of 343 patients Cancer Genet Cytogenet 1987 28: 293–299
Swansbury GJ, Lawler SD, Alimena G, Arthur D, Berger R, Van Den Berghe H, Bloomfield CD, de la Chapelle A, Dewald G, Garson OM, Hagemeijer A, Mitelman F, Rowley JD, Sakurai M . Long-term survival in acute myelogenous leukemia: a second follow-up of the Fourth International Workshop on Chromosomes in Leukemia Cancer Genet Cytogenet 1994 73: 1–7
Morel P, Hebbar M, Lai J-L, Duhamel A, Preudhomme C, Wattel E, Bauters F, Fenaux P . Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases Leukemia 1993 7: 1315–1323
Greenberg P, Cox C, Le Beau MM, Fenaux P, Morel P, Sanz G, Sanz M, Vallespi T, Hamblin T, Oscier D, Ohyashiki K, Toyama K, Aul C, Mufti G, Bennett J . International scoring system for evaluating prognosis in myelodysplastic syndromes Blood 1997 89: 2079–2088
Pedersen-Bjergaard J, Rowley JD . The balanced and the unbalanced chromosome aberrations of acute myeloid leukemia may develop in different ways and may contribute differently to malignant transformation Blood 1994 83: 2780–2786
Johansson B, Mertens F, Mitelman F . Primary versus secondary neoplasia associated chromosomal abnormalities – balanced rearrangements vs genomic imbalance? Genes Chromos Cancer 1996 16: 155–163
Erickson P, Gao J, Chang K-S, Look T, Whisenant E, Raimondi S, Lasher R, Trujillo J, Rowley JD, Drabkin H . Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of fusion transcript, AML1/ETO, with similarity to drosophila segmentation gene, runt Blood 1992 80: 1825–1831
Kakizuka A, Miller WH, Umesono K, Warrel RP, Frankel SR, Murty VVVS, Dmitrovsky E, Evans RM . Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RARalpha with a novel putative transcription factor, PML Cell 1991 66: 663–674
Collins SJ . Acute promyelocytic leukemia: relieving repression induces remission Blood 1998 91: 2631–2633
Dastugue N, Payen C, Lafage-Pachitaloff M, Bernard P, Leroux D, Huguet-Rigal F, Stoppa A-M, Marit G, Molina L, Michallet M, Maraninchi D, Attal M, Reiffers J for the BGMT group . Prognostic significance of karyotype in de novo adult acute myeloid leukemia Leukemia 1995 9: 1491–1498
Fialkow PJ, Singer JW, Raskind WH, Adamson JW, Jacobson RJ, Bernstein ID, Dow LW, Najfeld V, Veith R . Clonal development, stem-cell differentiation, and clinical remission in acute nonlymphocytic leukemia New Engl J Med 1987 317: 468–473
Leith CP, Kopecky KJ, Godwin J, McConnell T, Slovak ML, Chen I-M, Head DR, Appelbaum FR, Willman CL . Acute myeloid leukemia in the elderly: assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southwest Oncology Group Study Blood 1997 89: 3323–3329
Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnik HR, Sultan C . Proposals for the classification of the acute leukaemias Br J Haematol 1976 33: 451–458
Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C . Proposals for the classification of the myelodysplastic syndromes Br J Haematol 1982 51: 189–199
Mitelman F (ed) . ISCN 1991, Cancer Cytogenetics, Supplement to An International System for Human Cytogenetic Nomenclature Karger: Basel 1991
Brito-Babapulle F, Catovsky D, Galton DA . Clinical and laboratory features of de novo acute myeloid leukaemia with trilineage myelodysplasia Br J Haematol 1987 66: 445–450
Fenaux P, Morel P, Lai JL . Cytogenetics of myelodysplastic syndromes Semin Hematol 1996 33: 127–138
Rowley JD, Alimena G, Garson OM, Hagemeijer A, Mitelman F, Prigogina EL . A collaborative study of the relationship of the morphological type of acute nonlymphocytic leukemia with patient age and karyotype Blood 1982 59: 1013–1022
Stasi R, Del Poeta G, Masi M, Tribalto M, Venditti A, Papa G, Nicoletti B, Vernole P, Tedeschi B, Delaroche I, Mingarelli R, Dallapiccola B . Incidence of chromosome abnormalities and clinical significance of karyotype in de novo acute myeloid leukemia Cancer Genet Cytogenet 1993 67: 28–34
Baudard M, Marie JP, Cadiou M, Viguié F, Zittoun R . Acute myelogenous leukaemia in the elderly: retrospective study of 235 consecutive patients Br J Haematol 1994 86: 82–91
Grimwade D, Walker H, Oliver F, Wheatley K, Harrison C, Harrison G, Rees J, Hann I, Stevens R, Burnett A, Goldstone A on behalf of the Medical Research Council Adult and Children's Leukaemia Working Parties . The importance of diagnostic cytogenetics on outcome in AML: analysis of 1612 patients entered into the MRC AML10 trial Blood 1998 92: 2322–2333
Michels SD, McKenna RW, Arthur DC, Brunning RD . Therapy-related acute myeloid leukemia and myelodysplastic syndrome: a clinical and morphologic study of 65 cases Blood 1985 65: 1364–1372
Tamura S, Takemoto Y, Hashimoto-Tamaoki T, Mimura K, Sugahara Y, Senoh J, Furuyama JI, Kakishita E . Cytogenetic analysis of de novo acute myeloid leukemia with trilineage myelodysplasia in comparison with myelodysplastic syndrome evolving to acute myeloid leukemia Int J Oncol 1998 12: 1259–1262
Fugazza G, Bruzzone R, Dejana AM, Gobbi M, Ghio R, Patrone F, Rattenni S, Sessarego M . Cytogenetic clonality in chronic myelomonocytic leukemia studied with fluorescence in situ hybridization Leukemia 1995 9: 109–114
van Lom K, Hagemeijer A, Vandekerckhove F, Smit EM, Lowenberg B . Cytogenetic clonality analysis: typical patterns in myelodysplastic syndrome and acute myeloid leukemia Br J Haematol 1996 93: 594–600
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rossi, G., Pelizzari, A., Bellotti, D. et al. Cytogenetic analogy between myelodysplastic syndrome and acute myeloid leukemia of elderly patients. Leukemia 14, 636–641 (2000). https://doi.org/10.1038/sj.leu.2401711
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2401711
Keywords
This article is cited by
-
Older Patients with Acute Myeloid Leukemia Deserve Individualized Treatment
Current Oncology Reports (2022)
-
5q− syndrome-like features as the first manifestation of myelodysplastic syndrome in a patient with an unbalanced whole-arm translocation der(5;19)(p10;q10)
International Journal of Hematology (2017)
-
Survival improvement of poor-prognosis AML/MDS patients by maintenance treatment with low-dose chemotherapy and differentiating agents
Annals of Hematology (2014)
-
Hemogram and bone marrow morphology in children with chronic aplastic anemia and myelodysplastic syndrome
World Journal of Pediatrics (2008)
-
Inhibitors of DNA methylation: beyond myelodysplastic syndromes
Nature Clinical Practice Oncology (2005)